Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae
Bn. Kim et al., Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae, CHEMOTHERA, 46(5), 2000, pp. 303-308
Background: Resistance of Streptococcus pneumoniae to penicillin is now wid
espread and rapidly increasing all over the world. This has led to the crit
ical need for alternative antimicrobial therapy. Methods: To assess the act
ivities of antimicrobial combinations, including cefotaxime, ceftriaxone, v
ancomycin and meropenem, time-kill studies were conducted against five stra
ins of penicillin- and cephalosporin-resistant S. pneumoniae at clinically
achievable antimicrobial concentrations in cerebrospinal fluid. Results: Co
mbinations of an extended-spectrum cephalosporin with vancomycin were not s
ynergistic. Meropenem had a comparable bactericidal activity to those combi
nations, and its killing activity was not affected by the addition of cefot
axime, ceftriaxone or vancomycin. Conclusions: It is suggested that meropen
em could be an effective alternative for the treatment of penicillin- and c
ephalosporin-resistant pneumococcal meningitis. However, more clinical data
are required before it can be recommended as an effective antimicrobial ag
ent for such cases. Copyright (C) 2000 S. Karger AG, Basel.